Xeroderma pigmentosum (XP) is a rare genetic disorder that makes individuals extremely sensitive to ultraviolet (UV) rays from sunlight. This condition arises because of defects in the DNA repair mechanisms that normally correct damage caused by UV exposure. People with XP often develop severe sunburns after minimal sun exposure and are at a significantly increased risk for skin cancers and eye disorders at a young age. Understanding what xeroderma pigmentosum is due to defect in, the underlying genetic causes, and the biological mechanisms involved is essential for early diagnosis, management, and potential therapies.
What is Xeroderma Pigmentosum?
Xeroderma pigmentosum is primarily a disorder of DNA repair. When skin is exposed to ultraviolet light, DNA in skin cells can suffer damage in the form of thymine dimers or other lesions. In healthy individuals, specialized repair systems detect and correct these errors to prevent mutations. However, in individuals with XP, this repair process is defective, leading to the accumulation of DNA mutations that can cause skin abnormalities, premature aging, and an increased risk of cancers such as basal cell carcinoma, squamous cell carcinoma, and melanoma.
Genetic Basis of Xeroderma Pigmentosum
XP is inherited in an autosomal recessive manner, meaning that an affected individual must inherit two copies of the defective gene – one from each parent. Multiple genes have been identified as being involved in XP, each corresponding to a different complementation group, labeled XPA through XPG and XPV. These genes encode proteins that are essential for repairing UV-induced DNA damage.
- XPAPlays a critical role in recognizing damaged DNA and initiating repair.
- XPB and XPDInvolved in unwinding DNA so repair enzymes can access the damaged site.
- XPCRecognizes DNA distortions caused by UV-induced lesions.
- XPEHelps in the early steps of damage recognition.
- XPF and XPGAct as endonucleases that cut damaged DNA to remove it for repair.
- XPV (polymerase eta)Allows bypass of thymine dimers during DNA replication, preventing replication stalling and mutations.
Mechanism of Defect in XP
The primary defect in xeroderma pigmentosum is in the nucleotide excision repair (NER) pathway, which is the cellular system responsible for removing UV-induced DNA lesions. In a functional NER system, proteins detect the damaged DNA, excise a short single-stranded segment containing the damage, and fill in the gap with newly synthesized DNA. In XP patients, mutations in any of the NER genes disrupt this repair process. This failure results in persistent DNA lesions, genomic instability, and a higher propensity for mutations that can lead to cancer.
Types of DNA Damage in XP
The most common type of UV-induced DNA damage in XP is the formation of thymine dimers, where two adjacent thymine bases bond abnormally. Other types of damage include cyclobutane pyrimidine dimers and 6-4 photoproducts. Normally, NER proteins excise these lesions before they can interfere with DNA replication. In XP, defective repair leads to accumulation of these lesions, causing cells to either die, mutate, or transform into cancerous cells.
Clinical Features of Xeroderma Pigmentosum
Symptoms of XP usually appear in early childhood. These may include extreme sensitivity to sunlight, freckling in sun-exposed areas, dry or thin skin, and premature aging of the skin. Eyes are also highly affected due to UV exposure, leading to photophobia, keratitis, and even cancers of the eyelids or conjunctiva. Neurological abnormalities may be present in some XP patients, particularly those with XPA or XPD mutations, including hearing loss, cognitive impairment, or coordination difficulties.
Skin Manifestations
- Severe sunburns after minimal sun exposure
- Hyperpigmentation or hypopigmentation of affected areas
- Telangiectasia (visible small blood vessels)
- High risk of developing basal cell carcinoma, squamous cell carcinoma, and melanoma at an early age
Eye and Neurological Involvement
- Photophobia (sensitivity to light)
- Keratitis and conjunctivitis
- In some cases, progressive neurodegeneration with cognitive decline, hearing loss, or motor difficulties
Diagnosis of Xeroderma Pigmentosum
Diagnosing XP involves a combination of clinical evaluation, family history, and laboratory testing. DNA repair assays can be conducted on skin fibroblasts to assess the nucleotide excision repair capacity. Genetic testing can identify mutations in XP-related genes, confirming the diagnosis and helping determine the specific complementation group. Early diagnosis is crucial because protective measures can significantly reduce the risk of UV-induced cancers and improve the patient’s quality of life.
Diagnostic Tests
- UV sensitivity testing using cultured skin cells
- DNA repair assays (measuring excision repair activity)
- Genetic testing for mutations in XPA, XPB, XPC, and other relevant genes
Management and Prevention
There is currently no cure for xeroderma pigmentosum, so management focuses on prevention and early detection of skin and eye complications. Strict sun protection is essential, including the use of broad-spectrum sunscreens, protective clothing, UV-blocking sunglasses, and limiting outdoor activities during peak sunlight hours. Regular dermatological examinations help detect precancerous or cancerous lesions early, improving treatment outcomes. In some cases, surgical removal of skin cancers or precancerous growths is necessary. Supportive care may also include managing eye problems and neurological symptoms if present.
Advanced Therapies and Research
Emerging research in gene therapy and nucleotide excision repair enhancement holds promise for XP patients. Scientists are exploring ways to correct the defective DNA repair genes or boost alternative repair pathways to reduce the accumulation of mutations. Although still experimental, these approaches offer hope for future treatments that target the underlying cause of XP rather than just its symptoms.
Living with Xeroderma Pigmentosum
Living with XP requires a lifelong commitment to UV protection and medical monitoring. Families and patients must adapt their lifestyles to minimize sun exposure, including indoor schooling or work environments, specialized UV-filtering films on windows, and careful planning of outdoor activities. Psychosocial support is also important, as children with XP may face social challenges due to their condition and strict lifestyle restrictions. Community resources and support groups can provide guidance, encouragement, and coping strategies for both patients and their families.
Xeroderma pigmentosum is due to defects in the nucleotide excision repair pathway, caused by mutations in genes such as XPA, XPB, XPC, and others. These genetic defects prevent the repair of UV-induced DNA damage, leading to extreme photosensitivity, skin cancers, eye problems, and sometimes neurological issues. While there is no cure, early diagnosis, rigorous sun protection, regular medical monitoring, and ongoing research offer hope for better management and improved quality of life. Understanding the genetic and molecular basis of XP is key to preventing complications and supporting affected individuals in living safe and fulfilling lives.